Additionally, in connection to other cardiac parameters, nobiletin reduced MMP-2 and MMP-9 enzymatic activities in the heart, improved the cardiac hypertrophy index, attenuated the deterioration in the morphology of cardiomyocytes, and reduced diabetes-induced myocardial fibrosis in the rats. Here, MMP2 is linked to diabetes mellitus.